# Princeton BioPharma Capital Partners

Princeton BioPharma Capital Partners is a Private Equity based in Bridgewater, United States.

## Overview

- **Organization type:** Private Equity
- **Headquarters:** Bridgewater, United States
- **Region:** North America
- **Address:** Bridgewater, NJ, United States
- **Founded:** 2010
- **Assets under management:** Undisclosed
- **Website:** www.princetonbcp.com
- **LinkedIn:** https://www.linkedin.com/company/princeton-biopharma-capital-partners-llc

## Regulatory record

- **Reports private funds:** No

## About

Princeton Biopharma Capital Partners is a private equity firm that invests in commercial stage healthcare companies. It has made six investments to date. The firm's most recent investment was in Fidelis Animal Health as part of its Series A funding transaction on July 21, 2021.

## Sectors

- Healthcare Services
- Pharma & Biotech
- Medical Devices

## Questions

### What investment stages does Princeton BioPharma Capital Partners target?

Per the firm's own strategy description, Princeton BioPharma covers four distinct stages: early-stage startups, growth equity, corporate divestitures, and restructurings. This spans pre-revenue platforms through mature carve-outs from large pharmaceutical companies. The common thread across stages is transitional complexity — companies moving between ownership structures, regulatory phases, or commercial maturity levels that require more than passive capital.

### What is the firm's geographic investment focus?

The firm invests primarily in the Mid-Atlantic and Northeastern United States, where the highest concentration of pharmaceutical companies, academic medical centers, and FDA-registered manufacturing facilities is located. This regional concentration supports the hands-on operational model required for transitional life-science investing. No international mandate has been disclosed.

## Related profiles

- [Princess Private Equity Holding](https://altss.com/profile/princess-private-equity-holding)
- [Princeton Equity Group](https://altss.com/profile/princeton-equity-group)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/princeton-biopharma-capital-partners

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology